← Browse by Condition
Medical Condition
esophageal squamous cell carcinoma
Total Trials
17
Recruiting Now
17
Trial Phases
Phase 2, Phase 1, Phase 3
ClinicalMetric tracks all active clinical trials for esophageal squamous cell carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — esophageal squamous cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for esophageal squamous cell carcinoma?
ClinicalMetric currently tracks 17 actively recruiting clinical trials for esophageal squamous cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 17. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for esophageal squamous cell carcinoma?
esophageal squamous cell carcinoma research spans Phase 1 (5 trials), Phase 2 (10 trials), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a esophageal squamous cell carcinoma clinical trial?
Eligibility criteria for esophageal squamous cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 5
Phase 2 10
Phase 3 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06885814 Phase 2
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
NCT04389632 Phase 1
Recruiting
Enrollment
1,006 pts
Location
United States, Franc...
Sponsor
Seagen, a wholly owned subsidi...
NCT04807673 Phase 3
Recruiting
Enrollment
342 pts
Location
China
Sponsor
Tianjin Medical University Can...
NCT07088354
Recruiting
Enrollment
300 pts
Location
China
Sponsor
Tongji Hospital
NCT07266493 Phase 2
Recruiting
Enrollment
26 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT07385001 Phase 1, Phase 2
Recruiting
Enrollment
45 pts
Location
China
Sponsor
Tang-Du Hospital
NCT06780111 Phase 1, Phase 2
Recruiting
Enrollment
298 pts
Location
United States, Brazi...
Sponsor
Merck Sharp & Dohme LLC
NCT06056336 Phase 2
Recruiting
Enrollment
73 pts
Location
China
Sponsor
Guo Xufeng
NCT06747585 Phase 1, Phase 2
Recruiting
Enrollment
170 pts
Location
United States, Franc...
Sponsor
Alentis Therapeutics AG
NCT06971848
Recruiting
Enrollment
70 pts
Location
France
Sponsor
University Hospital, Angers
NCT05252078 Phase 2
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...
NCT04009265 Phase 3
Recruiting
Enrollment
819 pts
Location
China
Sponsor
Fujian Medical University Unio...
NCT07519486 Phase 2
Recruiting
Enrollment
118 pts
Location
China
Sponsor
Sichuan University
NCT04138212 Phase 3
Recruiting
Enrollment
456 pts
Location
China
Sponsor
Henan Cancer Hospital
NCT03964753 Phase 2
Recruiting
Enrollment
202 pts
Location
China
Sponsor
Hebei Medical University Fourt...
NCT07152678 Phase 2
Recruiting
Enrollment
60 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT07217171 Phase 1
Recruiting
Enrollment
160 pts
Location
United States
Sponsor
EvolveImmune United, Inc
Related Conditions
cutaneous squamous cell cancer (2) cervical squamous cell carcinoma (2) carcinoma non small cell lung (1) squamous cell carcinoma of head and neck (1) her2 negative breast neoplasms (1) esophageal adenocarcinoma (1) gastroesophageal junction adenocarcinoma (1) ovarian neoplasms (1) exocrine pancreatic adenocarcinoma (1) urinary bladder neoplasms (1) uterine cervical neoplasms (1) stomach neoplasms (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology